Statistics

Total Visits

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials15

Select a period of time:

Number of views in the range

Views
The JAK inhibitor tofacitinib for active rheumatoid arthritis: Results from Phase III trials8

Views

Views
November 20231
December 20230
January 20241
February 20241
March 20241
April 20240
May 20244
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States8
 

Top cities views

Views
Ashburn2
Boardman1
Chicago1